{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:23:17Z","timestamp":1793658197775,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009576","name":"Nantong City Health Commission","doi-asserted-by":"publisher","award":["MSZ2024003"],"award-info":[{"award-number":["MSZ2024003"]}],"id":[{"id":"10.13039\/501100009576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103435"],"award-info":[{"award-number":["82103435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cellsig.2025.112210","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:53:37Z","timestamp":1762264417000},"page":"112210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["RFC5 enhances DNA damage response and immune escape via suppressing the cGAS-STING pathway in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"138","author":[{"given":"Yumo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10192","key":"10.1016\/j.cellsig.2025.112210_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112210_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112210_bb0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41467-022-28158-2","article-title":"USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.cellsig.2025.112210_bb0025","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/nar\/gkl465","article-title":"The fidelity of DNA synthesis by yeast DNA polymerase zeta alone and with accessory proteins","volume":"34","author":"Zhong","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112210_bb0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.5114\/aoms.2018.73091","article-title":"Polymorphisms in MTHFR, MTR, RFC1 and C\u00dfS genes involved in folate metabolism and thyroid cancer: a case-control study","volume":"15","author":"Zara-Lopes","year":"2019","journal-title":"Arch. Med. Sci."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112210_bb0035","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1002\/jcp.29676","article-title":"RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells","volume":"235","author":"Hu","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112210_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100803","article-title":"Corrigendum to \u2018up-regulation of RFC3 promotes triple negative breast Cancer metastasis and is associated with poor prognosis via EMT\u2019 [translational oncology 10 (2017); 1-9]","volume":"13","author":"He","year":"2020","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0045","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/s41467-021-22971-x","article-title":"An RFC4\/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112210_bb0050","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112210_bb0055","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112210_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41419-020-02880-5","article-title":"Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112210_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100933","article-title":"CPSF6-mediated XBP1 3\u2019UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma","volume":"68","author":"Zhu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112210_bb0070","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","article-title":"Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112210_bb0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112210_bb0080","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Shen","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112210_bb0085","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin Chemoresistance by enhancing ac4C-associated DNA repair in bladder Cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0090","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","article-title":"Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.112210_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112758","article-title":"Chemotherapy and chemo-resistance in nasopharyngeal carcinoma","volume":"207","author":"Guan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112210_bb0105","first-page":"1343","article-title":"Multifaceted regulation and functions of replication factor C family in human cancers","volume":"8","author":"Li","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"8002","key":"10.1016\/j.cellsig.2025.112210_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-023-07009-0","article-title":"Genetic determinants of micronucleus formation in vivo","volume":"627","author":"Adams","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","article-title":"Catastrophic nuclear envelope collapse in cancer cell micronuclei","volume":"154","author":"Hatch","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112210_bb0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112210_bb0125","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112210_bb0130","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.112210_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109748","article-title":"CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma","volume":"123","author":"Di","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41419-024-06419-w","article-title":"CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-020-03302-2","article-title":"LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-024-03049-0","article-title":"CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair","volume":"43","author":"Qu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6708","key":"10.1016\/j.cellsig.2025.112210_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk5901","article-title":"Mechanism of PCNA loading by Ctf18-RFC for leading-strand DNA synthesis","volume":"385","author":"Yuan","year":"2024","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112210_bb0160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mc.23523","article-title":"RFC5, regulated by circ_0038985\/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer","volume":"62","author":"Yao","year":"2023","journal-title":"Mol. Carcinog."},{"issue":"20","key":"10.1016\/j.cellsig.2025.112210_bb0165","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-22-0991","article-title":"CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin Chemoresistance by facilitating YBX1 nuclear localization","volume":"28","author":"Hong","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add0960","article-title":"TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"issue":"7668","key":"10.1016\/j.cellsig.2025.112210_bb0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112210_bb0180","first-page":"1452","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Can."},{"issue":"18","key":"10.1016\/j.cellsig.2025.112210_bb0185","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1158\/0008-5472.CAN-23-0329","article-title":"NR1D1 stimulates antitumor immune responses in breast Cancer by activating cGAS-STING signaling","volume":"83","author":"Ka","year":"2023","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112210_bb0190","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","article-title":"NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance","volume":"35","author":"Chen","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0195","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-023-37096-6","article-title":"Polymerase \u03b8 inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer","volume":"14","author":"Patterson-Fortin","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0200","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-023-36523-y","article-title":"TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.112210_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108642","article-title":"Cisplatin in the era of PARP inhibitors and immunotherapy","volume":"258","author":"Duan","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112210_bb0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41698-024-00601-1","article-title":"Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma","volume":"8","author":"Liu","year":"2024","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.cellsig.2025.112210_bb0215","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221096214","article-title":"Current status and advances of immunotherapy in nasopharyngeal carcinoma","volume":"14","author":"Xu","year":"2022","journal-title":"Ther Adv Med Oncol"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825006254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825006254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:58:24Z","timestamp":1773305904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825006254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0898656825006254"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112210","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RFC5 enhances DNA damage response and immune escape via suppressing the cGAS-STING pathway in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112210"}}